More recent studies have shown CCT subunit 3 (CCT3) upregulation in hepatocellular carcinoma (HCC), cholangiocarcinoma and colon cancer [17–19], and that overexpression of CCT3 in HCC patients is associated with poor prognosis [20]. This evidence concerns the gene CCT3 and colonic neoplasm.